Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Disodium guanosine monophosphate is the disodium salt of guanosine 5'-monophosphate (GMP), a nucleotide consisting of the phosphate group, the ribose sugar, and the nucleobase guanine. As a small molecule, it occurs widely in nature as an RNA monomer and is commercially produced for use as a flavor enhancer in foods and as a pharmaceutical or dietary supplement. Its primary mechanism as a food additive is to act as a flavor potentiator, intensifying umami taste in combination with monosodium glutamate and other nucleotides. When used pharmaceutically (often in combination with other agents, such as lactoferrin), it may function by influencing hepcidin levels and iron metabolism[1][3]. No intrinsic pharmacological effect on molecular targets in humans as a single agent is routinely described, and it is generally considered safe as a food additive[13][14].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on disodium guanosine monophosphate.